Showing 1 - 4 results of 4 for search 'Liliane N. Byamungu', query time: 0.04s Refine Results
  1. 1
    Effectiveness of COVID-19 Pfizer-BioNTech (BNT162b2) mRNA vaccination in adolescents aged 12-17 years: A systematic review and meta-analysis

    Effectiveness of COVID-19 Pfizer-BioNTech (BNT162b2) mRNA vaccination in adolescents aged 12-17 years: A systematic review and meta-analysis by Patrick DMC. Katoto, Jacques L. Tamuzi, Amanda S. Brand, Diana M. Marangu, Liliane N. Byamungu, Charles S. Wiysonge, Glenda Gray

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Predictors associated with critical care need and in-hospital mortality among children with laboratory-confirmed COVID-19 infection in a high HIV infection burden region

    Predictors associated with critical care need and in-hospital mortality among children with laboratory-confirmed COVID-19 infection in a high HIV infection burden region by Liliane N. Byamungu, Liliane N. Byamungu, Jean B. Nachega, Jean B. Nachega, Jean B. Nachega, Jean B. Nachega, Ashendri Pillay, Patrick D. M. C. Katoto, Patrick D. M. C. Katoto, Patrick D. M. C. Katoto, Prakash Jeena, Lindsay Zurba, Refiloe Masekela

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Immunogenicity and reactogenicity of COVID-19 Pfizer-BioNTech (Bnt162b2) mRNA vaccination in immunocompromised adolescents and young adults: a systematic review and meta-analyses

    Immunogenicity and reactogenicity of COVID-19 Pfizer-BioNTech (Bnt162b2) mRNA vaccination in immunocompromised adolescents and young adults: a systematic review and meta-analyses by Patrick DMC Katoto, Mireille AM Kakubu, Jacques L. Tamuzi, Amanda S. Brand, Adaeze Ayuk, Liliane N. Byamungu, Charles S. Wiysonge, Glenda Gray

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Safety of COVID-19 Pfizer-BioNtech (BNT162b2) mRNA vaccination in adolescents aged 12-17 years: A systematic review and meta-analysis

    Safety of COVID-19 Pfizer-BioNtech (BNT162b2) mRNA vaccination in adolescents aged 12-17 years: A systematic review and meta-analysis by Patrick D. M. C. Katoto, Amanda S. Brand, Liliane N. Byamungu, Jacques L. Tamuzi, Tamirirashe C. Mahwire, Marcel K. Kitenge, Charles S. Wiysonge, Glenda Gray

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: